105 related articles for article (PubMed ID: 8505147)
1. Beneficial effects of SK&F 105685 in rat adjuvant arthritis: prophylactic and therapeutic effects on disease parameter progression.
Badger AM; Swift BA; Webb EF; Clark RK; Bugelski PJ; Griswold DE
Int J Immunopharmacol; 1993 Apr; 15(3):343-52. PubMed ID: 8505147
[TBL] [Abstract][Full Text] [Related]
2. Effects of a novel azaspirane (SK&F 105685) on arthritic lesions in the adjuvant Lewis rat: attenuation of the inflammatory process and preservation of skeletal integrity.
High WB; Bugelski PJ; Nichols ME; Swift BA; Solleveld HA; Badger AM
J Rheumatol; 1994 Mar; 21(3):476-83. PubMed ID: 8006892
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of animal models of autoimmune disease and the induction of non-specific suppressor cells by SK&F 105685 and related azaspiranes.
Badger AM; Dimartino MJ; Talmadge JE; Picker DH; Schwartz DA; Dorman JW; Mirabelli CK; Hanna N
Int J Immunopharmacol; 1989; 11(7):839-46. PubMed ID: 2532178
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic activity of SK&F 105685, a novel azaspirane with suppressor-cell inducing activity.
Badger AM; Swift BA
Clin Exp Rheumatol; 1993; 11 Suppl 8():S107-9. PubMed ID: 8324933
[TBL] [Abstract][Full Text] [Related]
5. Effects of SK&F 105685, a novel anti-arthritic agent, on immune function in the dog.
Kaplan JM; Badger AM; Ruggieri EV; Swift BA; Bugelski PJ
Int J Immunopharmacol; 1993 Feb; 15(2):113-23. PubMed ID: 8468115
[TBL] [Abstract][Full Text] [Related]
6. Disease-modifying activity of SK&F 106615 in rat adjuvant-induced arthritis. Multiparameter analysis of disease magnetic resonance imaging and bone mineral density measurements.
Bradbeer JN; Kapadia RD; Sarkar SK; Zhao H; Stroup GB; Swift BA; Rieman DJ; Badger AM
Arthritis Rheum; 1996 Mar; 39(3):504-14. PubMed ID: 8607900
[TBL] [Abstract][Full Text] [Related]
7. Selective immunomodulatory activity of SK&F 106615, a macrophage-targeting antiarthritic compound, on antibody and cellular responses in rats and mice.
Badger AM; Newman-Tarr TM; Satterfield JL
Immunopharmacology; 1997 Aug; 37(1):53-61. PubMed ID: 9285244
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of lymphoproliferative responses by SK&F 105685, a novel anti-arthritic agent.
Kaplan JM; Badger AM; Ruggieri EV; Olivera DL; Newman-Tarr T; Bugelski PJ
J Clin Lab Immunol; 1991 Dec; 36(4):49-58. PubMed ID: 1668843
[TBL] [Abstract][Full Text] [Related]
9. The effect of SK&F 105685, a novel suppressor cell-inducing compound, in the adjuvant arthritic rat.
Badger AM; Swift BA; Bugelski PJ; High WB; DiMartino MJ; Greig R
Br J Rheumatol; 1991; 30 Suppl 2():66-9. PubMed ID: 1825183
[No Abstract] [Full Text] [Related]
10. Induction of suppressor cell activity in vivo and suppression of lymphoproliferative responses in vitro by SK&F 105.685 in the dog.
Thiem PA; Kaplan JM; Bugelski PJ; Ruggieri EV; Badger AM
Immunopharmacology; 1992; 23(2):67-74. PubMed ID: 1534791
[TBL] [Abstract][Full Text] [Related]
11. Antiarthritic and suppressor cell inducing activity of azaspiranes: structure-function relationships of a novel class of immunomodulatory agents.
Badger AM; Schwartz DA; Picker DH; Dorman JW; Bradley FC; Cheeseman EN; DiMartino MJ; Hanna N; Mirabelli CK
J Med Chem; 1990 Nov; 33(11):2963-70. PubMed ID: 2146392
[TBL] [Abstract][Full Text] [Related]
12. Induction of non-specific suppressor cells in normal Lewis rats by a novel azaspirane SK&F 105685.
Badger AM; King AG; Talmadge JE; Schwartz DA; Picker DH; Mirabelli CK; Hanna N
J Autoimmun; 1990 Aug; 3(4):485-500. PubMed ID: 2145847
[TBL] [Abstract][Full Text] [Related]
13. Effect of FTY720, a novel immunosuppressant, on adjuvant-induced arthritis in rats.
Matsuura M; Imayoshi T; Chiba K; Okumoto T
Inflamm Res; 2000 Aug; 49(8):404-10. PubMed ID: 11028757
[TBL] [Abstract][Full Text] [Related]
14. Effect of auranofin treatment on aberrant splenic interleukin production in adjuvant arthritic rats.
Lee JC; Dimartino MJ; Votta BJ; Hanna N
J Immunol; 1987 Nov; 139(10):3268-74. PubMed ID: 3500212
[TBL] [Abstract][Full Text] [Related]
15. NE-58095: a diphosphonate which prevents bone erosion and preserves joint architecture in experimental arthritis.
Francis MD; Hovancik K; Boyce RW
Int J Tissue React; 1989; 11(5):239-52. PubMed ID: 2517540
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and functional analysis of rat bronchoalveolar macrophages containing chemically induced phospholipid inclusions.
Waites CR; Bugelski PJ; Badger AM
Toxicol Appl Pharmacol; 1995 Feb; 130(2):316-21. PubMed ID: 7871542
[TBL] [Abstract][Full Text] [Related]
17. The azaspirane SKF 105685 ameliorates renal allograft rejection in rats.
Fan PY; Albrightson CR; Howell DN; Best C; Badger AM; Coffman TM
J Am Soc Nephrol; 1993 Apr; 3(10):1680-5. PubMed ID: 8318684
[TBL] [Abstract][Full Text] [Related]
18. Induction of non-specific suppressor cells and myeloregulatory effects of an immunomodulatory azaspirane, SK&F 105685.
King AG; Olivera D; Talmadge JE; Badger AM
Int J Immunopharmacol; 1991; 13(1):91-100. PubMed ID: 1827431
[TBL] [Abstract][Full Text] [Related]
19. NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis.
Cicala C; Ianaro A; Fiorucci S; Calignano A; Bucci M; Gerli R; Santucci L; Wallace JL; Cirino G
Br J Pharmacol; 2000 Jul; 130(6):1399-405. PubMed ID: 10903982
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of TRK-530 on rat adjuvant arthritis.
Tanahashi M; Funaba Y; Itoh M; Kawabe N; Nakadate-Matsushita T
Pharmacology; 1998 May; 56(5):242-51. PubMed ID: 9597691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
